| Bioactivity | N6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM for human A1, A2A and A3 receptors, respectively[1][2]. | ||||||||||||
| Target | Ki: 2.3 nM (A1), 790 nM (A2A), 43 nM(A3). | ||||||||||||
| Name | N6-Cyclopentyladenosine | ||||||||||||
| CAS | 41552-82-3 | ||||||||||||
| Formula | C15H21N5O4 | ||||||||||||
| Molar Mass | 335.36 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Klotz KN, et al. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):382-91. [2]. Soliño M, et al. Adenosine A1 receptor: A neuroprotective target in light induced retinal degeneration. PLoS One. 2018 Jun 18;13(6):e0198838. |
N6-Cyclopentyladenosine
CAS: 41552-82-3 F: C15H21N5O4 W: 335.36
N6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM f
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.